BLANK ROME GOVERNMENT RELATIONS for EMERGENT BIOSOLUTIONS INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
FY22 NDAA - provisions related to biological and chemical defense and access to naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL FLEMING LEGG | — |
| STEPHEN PERANICH | — |
Budget/Appropriations BUD
FY22 Appropriations funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GENEVIEVE COWAN | — |
| MICHAEL FLEMING LEGG | — |
| STEPHEN PERANICH | — |
Disaster Planning/Emergencies DIS
S.4231 - Preparing for the Next Pandemic Act. Issues related to the development, manufacture, and distribution of coronavirus vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL FLEMING LEGG | — |
| STEPHEN PERANICH | — |
Health Issues HCR
State Opioid Response Grants funding. Substance Abuse and Mental Health Block Grant funding. CARA 3.0 - Comprehensive Addiction and Recovery Act. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021. H.R. 2366 and S. 1457 - the Stop Fentanyl Act. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL FLEMING LEGG | — |
| STEPHEN PERANICH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.